<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10(1)</volume><submitter>Malagi AV</submitter><pubmed_abstract>Non-invasive characterization of pancreatic masses aids in the management of pancreatic lesions. Intravoxel incoherent motion-diffusion kurtosis imaging (IVIM-DKI) and machine learning-based texture analysis was used to differentiate pancreatic masses such as pancreatic ductal adenocarcinoma (PDAC), pancreatic neuroendocrine tumor (pNET), solid pseudopapillary epithelial neoplasm (SPEN), and mass-forming chronic pancreatitis (MFCP). A total of forty-eight biopsy-proven patients with pancreatic masses were recruited and classified into pNET (&lt;i>n&lt;/i> = 13), MFCP (&lt;i>n&lt;/i> = 6), SPEN (&lt;i>n&lt;/i> = 4), and PDAC (&lt;i>n&lt;/i> = 25) groups. All patients were scanned for IVIM-DKI sequences acquired with 14 &lt;i>b&lt;/i>-&lt;i>values&lt;/i> (0 to 2500 s/mm&lt;sup>2&lt;/sup>) on a 1.5T MRI. An IVIM-DKI model with a 3D total variation (TV) penalty function was implemented to estimate the precise IVIM-DKI parametric maps. Texture analysis (TA) of the apparent diffusion coefficient (ADC) and IVIM-DKI parametric map was performed and reduced using the chi-square test. These features were fed to an artificial neural network (ANN) for characterization of pancreatic mass subtypes and validated by 5-fold cross-validation. Receiver operator characteristics (ROC) analyses were used to compute the area under curve (AUC). Perfusion fraction (f) was significantly higher (&lt;i>p&lt;/i> &amp;lt; 0.05) in pNET than PDAC. The f showed better diagnostic performance for PDAC vs. MFCP with AUC:0.77. Both pseudo-diffusion coefficient (D*) and f for PDAC vs. pNET showed an AUC of 0.73. ADC and diffusion coefficient (D) showed good diagnostic performance for pNET vs. MFCP with AUC: 0.79 and 0.76, respectively. In the TA of PDAC vs. non-PDAC, f and combined IVIM-DKI parameters showed high accuracy ≥ 84.3% and AUC ≥ 0.84. Mean f and combined IVIM-DKI parameters estimated that the IVIM-DKI model with TV texture features has the potential to be helpful in characterizing pancreatic masses.</pubmed_abstract><journal>Bioengineering (Basel, Switzerland)</journal><pagination>83</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9854749</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Pancreatic Mass Characterization Using IVIM-DKI MRI and Machine Learning-Based Multi-Parametric Texture Analysis.</pubmed_title><pmcid>PMC9854749</pmcid><pubmed_authors>Malagi AV</pubmed_authors><pubmed_authors>Mehndiratta A</pubmed_authors><pubmed_authors>Sharma R</pubmed_authors><pubmed_authors>Gamanagatti S</pubmed_authors><pubmed_authors>Kandasamy D</pubmed_authors><pubmed_authors>Gupta SD</pubmed_authors><pubmed_authors>Garg P</pubmed_authors><pubmed_authors>Shivaji S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Pancreatic Mass Characterization Using IVIM-DKI MRI and Machine Learning-Based Multi-Parametric Texture Analysis.</name><description>Non-invasive characterization of pancreatic masses aids in the management of pancreatic lesions. Intravoxel incoherent motion-diffusion kurtosis imaging (IVIM-DKI) and machine learning-based texture analysis was used to differentiate pancreatic masses such as pancreatic ductal adenocarcinoma (PDAC), pancreatic neuroendocrine tumor (pNET), solid pseudopapillary epithelial neoplasm (SPEN), and mass-forming chronic pancreatitis (MFCP). A total of forty-eight biopsy-proven patients with pancreatic masses were recruited and classified into pNET (&lt;i>n&lt;/i> = 13), MFCP (&lt;i>n&lt;/i> = 6), SPEN (&lt;i>n&lt;/i> = 4), and PDAC (&lt;i>n&lt;/i> = 25) groups. All patients were scanned for IVIM-DKI sequences acquired with 14 &lt;i>b&lt;/i>-&lt;i>values&lt;/i> (0 to 2500 s/mm&lt;sup>2&lt;/sup>) on a 1.5T MRI. An IVIM-DKI model with a 3D total variation (TV) penalty function was implemented to estimate the precise IVIM-DKI parametric maps. Texture analysis (TA) of the apparent diffusion coefficient (ADC) and IVIM-DKI parametric map was performed and reduced using the chi-square test. These features were fed to an artificial neural network (ANN) for characterization of pancreatic mass subtypes and validated by 5-fold cross-validation. Receiver operator characteristics (ROC) analyses were used to compute the area under curve (AUC). Perfusion fraction (f) was significantly higher (&lt;i>p&lt;/i> &amp;lt; 0.05) in pNET than PDAC. The f showed better diagnostic performance for PDAC vs. MFCP with AUC:0.77. Both pseudo-diffusion coefficient (D*) and f for PDAC vs. pNET showed an AUC of 0.73. ADC and diffusion coefficient (D) showed good diagnostic performance for pNET vs. MFCP with AUC: 0.79 and 0.76, respectively. In the TA of PDAC vs. non-PDAC, f and combined IVIM-DKI parameters showed high accuracy ≥ 84.3% and AUC ≥ 0.84. Mean f and combined IVIM-DKI parameters estimated that the IVIM-DKI model with TV texture features has the potential to be helpful in characterizing pancreatic masses.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2025-04-26T00:34:37.759Z</modification><creation>2025-04-06T09:48:58.634Z</creation></dates><accession>S-EPMC9854749</accession><cross_references><pubmed>36671655</pubmed><doi>10.3390/bioengineering10010083</doi></cross_references></HashMap>